The British Society for Rheumatology’s Case-Based Conference attracts top professionals and next generation rheumatologists from all over the country and abroad. Sponsorship will put your products and services in front of hundreds of decision making rheumatology professionals.
To discuss how the conference can work for you and your business please contact our Sponsorship Manager Emily MacKenzie.
Sponsored sessions at 2018's Case-Based Conference
We have the following sponsored sessions taking place at this year's conference:
Pfizer - Thursday 20 September
Contemporary immunopathogenic concepts and therapeutics options in psoriatic arthritis: 09:00 – 9:45, Abbey Room
Speaker - Professor Arthur Kavanaugh, Professor of Medicine, University of San Diego
Chair - Dr James Galloway, Kings College London
This 45 minute session will comprise a 25 minute keynote lecture delivered by Professor Arthur Kavanaugh, (Professor of Medicine, University of San Diego) on advances in our understanding of the immunopathegenic mechanisms underlying PsA and the associated complications. This will be followed by a 15 minute presentation by Dr James Galloway (Senior Lecturer in Rheumatology, King's College London), who will provide an overview on some of the recent clinical trial programmes for novel therapeutics in PsA, with a focus on XELJANZ▼ (tofacitinab citrate). There will be a 5 minute Q&A at the end of the session.
Prescribing information for XELJANZ▼ (tofacitinib citrate) can be found on the eMC website https://www.medicines.org.uk/emc/
Sobi - Friday 21 September
Adult Onset Still’s disease an update and complex patient cases: 08:30 – 09:30, Abbey Room
Speaker - Dr Sinisa Savic, Consultant Immunologist, St James Hospital, Leeds, Dr Frances Hall, Consultant Rheumatologist, Addenbrookes Hospital, Cambridge
An introduction to Adult Onset Still’s disease including disease characteristics; laboratory, genetic and clinical features. To explore the complexities and challenges associated with diagnosis and treatment of the disease with examples of patient case studies.
Eli Lilly and Company - Friday 21 September
Managing the complexity of Psoriatic Arthritis: case study discussion
12:40 - 13:20, Abbey Room
Speakers: Prof Bruce Kirkham, Guy's and St Thomas' NHS Foundation Trust & Prof Mark Goodfield, Consultant Dermatologist, Leeds
Presentation of complex cases involving the multidisciplinary team involved in the care of patients with psoriatic arthritis. The content will highlight the complexities in the clinical decision making for patients with multiple co-morbidities. Discussion will include the challenges faced in selecting optimal treatment to maximise treatment outcomes for the co-morbid patient. The presentation will also include the latest data from the Taltz® (Ixekizumab) clinical trial programme and real world experience.
Prescribing information for Taltz®(Ixekizumab) can be found on the eMC website.
This symposium has been developed, funded and organised by Eli Lilly and Company, and Lilly products will be discussed as this meeting.
With thanks to our sponsors: